Anti malondialdehyde-adduct immunological response as a possible marker of successful aging (Q44633422)

4 December 2017

Anti malondialdehyde-adduct immunological response as a possible marker of successful aging (English)

1 reference

4 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

author name string

Nicola Traverso

1

1 reference

4 December 2017

Stefania Patriarca

2

1 reference

4 December 2017

Emanuela Balbis

3

1 reference

4 December 2017

Anna Lisa Furfaro

4

1 reference

4 December 2017

Damiano Cottalasso

5

1 reference

4 December 2017

Maria Adelaide Pronzato

6

1 reference

4 December 2017

Paolo Carlier

7

1 reference

4 December 2017

Federica Botta

8

1 reference

4 December 2017

Umberto Maria Marinari

9

1 reference

4 December 2017

Luigi Fontana

10

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14580866

25 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0531556503001888?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

https://api.elsevier.com/content/article/PII:S0531556503001888?httpAccept=text/plain

25 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

published in

Experimental Gerontology

1 reference

4 December 2017

38

1 reference

4 December 2017

10

1 reference

4 December 2017

1129-1135

1 reference

Effects of carbon tetrachloride, menadione, and paraquat on the urinary excretion of malondialdehyde, formaldehyde, acetaldehyde, and acetone in rats

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Alterations in mitochondrial membrane fluidity by lipid peroxidation products

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Influence of chronic ethanol consumption on toxic effects of 1,2-dichloroethane: glycolipoprotein retention and impairment of dolichol concentration in rat liver microsomes and Golgi apparatus

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

The metabolism of malondialdehyde

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Plasma protein oxidation and antioxidant defense during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Free radical theory of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Aging: phenomena and theories

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Extending functional life span

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Antioxidant enzyme activities and malondialdehyde levels related to aging

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Alterations of antioxidant enzymes and oxidative stress markers in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

The Haber-Weiss reaction and mechanisms of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Role of mitochondria in oxidative stress and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Determination of carbonyl content in oxidatively modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Cytokines, modified lipoproteins, and arteriosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Plasma antioxidants and longevity: a study on healthy centenarians.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Aldehydic products of lipid peroxidation do not directly activate rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dy

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Oxidative stress and advancing age: results in healthy centenarians.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Role of lipid peroxidation and the glutathione-dependent antioxidant system in the impairment of endothelium-dependent relaxations with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Role of oxidative stress and protein oxidation in the aging process

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Immunological memory and late onset autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Exposure to malondialdehyde induces an early redox unbalance preceding membrane toxicity in human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Immunological evidence for increased oxidative stress in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

On the role of aging in the etiology of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Increased plasma levels of glutathione and malondialdehyde after acute ethanol ingestion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Synergistic DNA damaging effects of malondialdehyde/Cu(II) in PM2 DNA and in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Autoantibodies against oxidized LDL. A potential marker for atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0531-5565%2803%2900188-8

7 January 2021

Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis

12

1 reference

https://api.crossref.org/works/10.1016/S0531-5565(03)00188-8

25 March 2024

Identifiers

1 reference

4 December 2017

1 reference